Critically ill patients with 2009 influenza A(H1N1) infection in Canada

Anand Kumar1, Ryan Zarychanski, Ruxandra Pinto

  • 1Section of Critical Care Medicine, Health Sciences Centre, JJ 399, 700 William Ave, Winnipeg, MB R3E-0Z3 Canada. akumar61@yahoo.com

JAMA
|October 14, 2009
PubMed

Insights

Critically ill patients with 2009 influenza A(H1N1) in Canada experienced rapid disease progression, severe hypoxemia, and organ failure. Outcomes included prolonged mechanical ventilation and significant mortality, highlighting the need for intensive care.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • The 2009 influenza A(H1N1) pandemic saw a significant number of cases in North America.
  • Understanding the characteristics of critically ill patients is crucial for managing severe influenza infections.

Purpose of the Study:

  • To characterize critically ill patients with 2009 influenza A(H1N1) in Canada.
  • To describe their treatment and outcomes, including mortality and resource utilization.

Main Methods:

  • Prospective observational study of 168 critically ill patients with confirmed or probable 2009 influenza A(H1N1).
  • Data collected from 38 Canadian adult and pediatric intensive care units (ICUs).
  • Primary outcomes: 28-day and 90-day mortality; Secondary outcomes: mechanical ventilation and ICU stay duration.

Main Results:

  • The study included young adults and children, with a high proportion of females and Aboriginal Canadians.
  • Patients presented with rapid critical illness, severe hypoxemia, and frequent multisystem organ failure.
  • High rates of mechanical ventilation (81.0%) and prolonged ICU stays (median 12 days) were observed, along with frequent use of rescue therapies.

Conclusions:

  • Critical illness from 2009 influenza A(H1N1) developed quickly, affecting young individuals.
  • Severe hypoxemia, organ failure, and prolonged mechanical ventilation were common, necessitating intensive care interventions.
Abstract

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...